Search results
ASCO: Novel CAR T therapy and shorter targeted the | Newswise
Newswise· 6 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions in 40% of patients with relapsed ...
Corey N. Martin
The Martinsburg Journal· 2 days agoCorey N. Martin Corey Nathaniel Martin, 20, of Charles Town, passed away Thursday, May 30, 2024, at home while surrounded by his loving family and under...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 6 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
90 Day Fiance’s Deavan Clegg Gives Rare Update on Son Taeyang’s Cancer Battle: ‘Thriving’
In Touch Weekly via Yahoo News· 6 days ago90 Day Fiancé alum Deavan Clegg shared a rare update about her son Taeyang's cancer battle while...
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 6 days ago"The data presented at ASCO 2024 demonstrate efficient and specific modulation of the oncogenic transcription factor MYB, a target that historically has been difficult to drug, by RGT-61159 ...
